These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34963744)

  • 1. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India.
    Goel S; Aggarwal A; Iqbal A; Talwar V; Mitra S; Singh S
    World J Gastroenterol; 2021 Dec; 27(45):7813-7830. PubMed ID: 34963744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the incidentally detected gallbladder cancer: algorithms and controversies.
    Cavallaro A; Piccolo G; Di Vita M; Zanghì A; Cardì F; Di Mattia P; Barbera G; Borzì L; Panebianco V; Di Carlo I; Cavallaro M; Cappellani A
    Int J Surg; 2014; 12 Suppl 2():S108-S119. PubMed ID: 25182380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.
    Cavallaro A; Piccolo G; Panebianco V; Lo Menzo E; Berretta M; Zanghì A; Di Vita M; Cappellani A
    World J Gastroenterol; 2012 Aug; 18(30):4019-27. PubMed ID: 22912553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center.
    Patkar S; Ostwal V; Ramaswamy A; Engineer R; Chopra S; Shetty N; Dusane R; Shrikhande SV; Goel M
    J Surg Oncol; 2018 Mar; 117(3):372-379. PubMed ID: 28940502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive Surgical Approach for Gallbladder Cancer: a Single-Center Experience from Northern India.
    Singh SK; Talwar R; Kannan N; Tyagi AK; Jaiswal P; Kumar A
    J Gastrointest Cancer; 2015 Dec; 46(4):399-407. PubMed ID: 26410686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience.
    D'Hondt M; Lapointe R; Benamira Z; Pottel H; Plasse M; Letourneau R; Roy A; Dagenais M; Vandenbroucke-Menu F
    Eur J Surg Oncol; 2013 Jun; 39(6):548-53. PubMed ID: 23522952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognosis after curative resection of gallbladder cancer with hilar invasion is similar to that of hilar cholangiocarcinoma.
    Nasu Y; Tanaka E; Hirano S; Tsuchikawa T; Kato K; Matsumoto J; Shichinohe T; Kondo S
    J Hepatobiliary Pancreat Sci; 2012 May; 19(3):274-80. PubMed ID: 21879321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
    Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
    J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).
    Duffy A; Capanu M; Abou-Alfa GK; Huitzil D; Jarnagin W; Fong Y; D'Angelica M; Dematteo RP; Blumgart LH; O'Reilly EM
    J Surg Oncol; 2008 Dec; 98(7):485-9. PubMed ID: 18802958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker.
    Sirivatanauksorn V; Dumronggittigule W; Dulnee B; Srisawat C; Sirivatanauksorn Y; Pongpaibul A; Masaratana P; Somboonyosdech C; Sripinitchai S; Kositamongkol P; Mahawithitwong P; Tovikkai C; Sangserestid P; Limsrichamrern S
    Surg Oncol; 2020 Mar; 32():57-62. PubMed ID: 31751820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.
    Cho JK; Lee W; Jang JY; Kim HG; Kim JM; Kwag SJ; Park JH; Kim JY; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Jeong CY
    World J Surg Oncol; 2019 Jan; 17(1):8. PubMed ID: 30616645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of surgical strategies on the survival of gallbladder cancer patients: analysis of 715 cases.
    Chang Y; Li Q; Wu Q; Chi L; Bi X; Zeng Q; Huo H
    World J Surg Oncol; 2020 Jun; 18(1):142. PubMed ID: 32590998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406).
    Higuchi R; Ono H; Matsuyama R; Takemura Y; Kobayashi S; Otsubo T; Abe Y; Endo I; Tanabe M; Yamamoto M;
    BMC Gastroenterol; 2022 Mar; 22(1):152. PubMed ID: 35346072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study.
    Chen M; Cao J; Xiang Y; Ma X; Bai Y; Lai Q; Tong C; Ma Z; Topatana W; Hu J; Li S; Juengpanich S; Yu H; Cai X
    Surgery; 2021 Jun; 169(6):1304-1311. PubMed ID: 33551070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation.
    Yuza K; Sakata J; Prasoon P; Hirose Y; Ohashi T; Toge K; Miura K; Nagahashi M; Kobayashi T; Wakai T
    BMC Cancer; 2020 Jan; 20(1):20. PubMed ID: 31907021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications.
    Chaudhari VA; Ostwal V; Patkar S; Sahu A; Toshniwal A; Ramaswamy A; Shetty NS; Shrikhande SV; Goel M
    HPB (Oxford); 2018 Sep; 20(9):841-847. PubMed ID: 29706425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis.
    Xiong YC; Yang ZY; Gong A; Wu ZY; Liu SL; Zhu YD; Song XL; Chu BF; Wu XS; Gong W
    Cancer Control; 2024; 31():10732748241271682. PubMed ID: 39105433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients.
    Lim H; Seo DW; Park DH; Lee SS; Lee SK; Kim MH; Hwang S
    J Clin Gastroenterol; 2013; 47(5):443-8. PubMed ID: 23188077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.